2012 Aarkstore.com | Genta Incorporated – Product Pipeline Review – 2012

1. Aarkstore.com announces, The Latest market research report is available in
its vast collection:
Genta Incorporated – Product Pipeline Review – 2012
You can also request for sample page of above mention reports on
sample@aarkstore.com
Summary
Global Markets Direct’s pharmaceuticals report, “Genta Incorporated - Product
Pipeline Review - 2012” provides data on the Genta Incorporated’s research and
development focus. The report includes information on current developmental
pipeline, complete with latest updates, and features on discontinued and dormant
projects.
This report is built using data and information sourced from Global Markets Direct’s
proprietary databases, Genta Incorporated’s corporate website, SEC filings, investor
presentations and featured press releases, both from Genta Incorporated and
industry-specific third party sources, put together by Global Markets Direct’s team.
Scope
- Genta Incorporated - Brief Genta Incorporated overview including business
description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of Genta Incorporated human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
Table of contents:
List of Tables 5

2. List of Figures 5
Genta Incorporated Snapshot 6
Genta Incorporated Overview 6
Key Information 6
Key Facts 6
Genta Incorporated – Research and Development Overview 7
Key Therapeutic Areas 7
Genta Incorporated – Pipeline Review 9
Pipeline Products by Stage of Development 9
Pipeline Products – Monotherapy 10
Pipeline Products – Combination Treatment Modalities 11
Genta Incorporated – Pipeline Products Glance 12
Genta Incorporated Clinical Stage Pipeline Products 12
Phase II Products/Combination Treatment Modalities 12
Phase I Products/Combination Treatment Modalities 13
Genta Incorporated – Drug Profiles 14
G4544 14
Product Description 14
Mechanism of Action 14
R&D Progress 14
Ganite 16
Product Description 16
Mechanism of Action 16
R&D Progress 16
Tesetaxel 17
Product Description 17
Mechanism of Action 17
R&D Progress 17
Tesetaxel + Capecitabine 19
Product Description 19
Mechanism of Action 19
R&D Progress 19
Tesetaxel + Cisplatin + Capecitabine 21
Product Description 21
Mechanism of Action 21

3. R&D Progress 21
List of Figures
List of Tables are also include.
For more related Reports Plz follow The link:
Product Pipeline Review – 2012
http://www.aarkstore.com/search/viewresults.asp?search=Product Pipeline
Review – 2012&PubId=&pagenum=1
Genta Incorporated – Product Pipeline Review – 2012
Geron Corporation – Product Pipeline Review – 2012
Glenmark Pharmaceuticals Ltd. – Product Pipeline Review – 2012
iBio, Inc. – Product Pipeline Review – 2012
ImmunoGen, Inc. – Product Pipeline Review – 2012
Can-Fite BioPharma Ltd. – Product Pipeline Review – 2012
Celtic Biotech, Ltd. – Product Pipeline Review – 2012
Cyclacel Pharmaceuticals Inc. – Product Pipeline Review – 2012
Endocyte, Inc. – Product Pipeline Review – 2012

4. Flamel Technologies S.A. – Product Pipeline Review – 2012
Search More Reports Related to This Category :
Pharmaceuticals and Healthcare
http://www.aarkstore.com/search/viewresults.asp?search=Pharmaceuticals and
Healthcare&PubId=&pagenum=1
For More details Plz do contact :
Aarkstore Enterprise
Lavanya
Phone:08149852585
Email: enquiry@aarkstore.com